TriSalus Life Sciences, Inc.

NasdaqGM:TLSI Stock Report

Market Cap: US$365.0m

TriSalus Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:TLSI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 May 25SellUS$45,087Jennifer StevensIndividual8,704US$5.18
19 May 25SellUS$34,172Richard MarshakIndividual6,597US$5.18
19 May 25SellUS$24,678Jodi DevlinIndividual4,764US$5.18
19 May 25SellUS$24,678Bryan CoxIndividual4,764US$5.18
05 Feb 25BuyUS$33,900James YoungIndividual6,000US$5.65
30 Jan 25BuyUS$51,754Mary SzelaIndividual10,040US$5.28
28 Jan 25BuyUS$157,200Sean MurphyIndividual30,000US$5.31
28 Jan 25BuyUS$24,146Mary SzelaIndividual4,716US$5.12
27 Jan 25BuyUS$129,600James YoungIndividual24,000US$5.40
27 Jan 25BuyUS$26,157Mary SzelaIndividual4,826US$5.42
17 Dec 24BuyUS$249,999Frankenius Equity ABCompany62,972US$3.97

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TLSI?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,447,7372.9%
Individual Insiders8,977,22918%
General Public16,440,19932.9%
Institutions23,099,14646.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 63.9%.

Top Shareholders

Top 25 shareholders own 63.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14%
Frankenius Equity AB
6,989,748US$51.1m12.2%100.0%
6.78%
Utmost Luxembourg S.A.
3,385,235US$24.7m71%14.39%
4.12%
Michael Stansky
2,057,865US$15.0m0%no data
4.08%
Nantahala Capital Management, LLC
2,040,245US$14.9m2.01%0.8%
3.24%
Mats Wahlstrom
1,617,853US$11.8m24.9%no data
3.1%
ORI Capital
1,546,569US$11.3m0%7.33%
2.74%
Hw Investment Partners, LLC
1,370,028US$10.0m0%no data
2.5%
AWM Investment Company Inc
1,250,000US$9.1m0%0.9%
2.32%
The Vanguard Group, Inc.
1,159,575US$8.5m42.4%no data
2.25%
Sands Point LLC
1,125,000US$8.2m0%no data
2.1%
James Pallotta
1,047,845US$7.7m0%no data
2.1%
Gilder Gagnon Howe & Co. LLC
1,047,059US$7.6m-4.2%0.08%
1.96%
Kerry Hicks
979,767US$7.2m90.4%no data
1.87%
David Matlin
931,904US$6.8m0%no data
1.58%
BlackRock, Inc.
787,864US$5.8m26.7%no data
1.29%
Wealthcare Advisory Partners LLC
643,740US$4.7m0%0.1%
1.25%
Christopher Dewey
623,983US$4.6m0%no data
1.24%
Sean Murphy
618,780US$4.5m0%no data
1.12%
Alyeska Investment Group, L.P.
557,500US$4.1m0%0.01%
1.11%
Geode Capital Management, LLC
554,455US$4.1m21.8%no data
0.65%
The Kerry Raymond Hicks Dynasty Trust
322,737US$2.4m0%no data
0.63%
Mary Szela
315,428US$2.3m0%no data
0.49%
George Martin
247,176US$1.8m0%no data
0.49%
Arjun Desai
247,127US$1.8m0%no data
0.39%
State Street Global Advisors, Inc.
192,633US$1.4m66.6%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/14 11:36
End of Day Share Price 2025/12/12 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

TriSalus Life Sciences, Inc. is covered by 7 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William PlovanicCanaccord Genuity
Ross OsbornCantor Fitzgerald & Co.
Justin WalshJonesTrading Institutional Services, LLC